RESUMO
OBJECTIVES: Mercury exposure is common and can be toxic, especially in children. Children are often drawn to elemental mercury because of its density, color, and proclivity to form beads. METHODS: We present data on 49 children with mercury intoxication (MI) and 60 children with mercury exposure from Turkey. RESULTS: The most common source of mercury was broken thermometer in schools. Inhaling mercury vapor was the most common route of exposure. The median exposure time was 6 (6-16) hours in the MI group, and the time to 1st symptoms was 10 (0-24) hours. In the MI group, the median blood mercury level was 21 µg/L (13-32.3), the median spot urine mercury level was 40 µg/L (7.66-78), and the median 24-hour urine mercury level was 25.8 µg/L (11-64). The most common symptoms in patients with MI were malaise, muscle pain, muscle cramps, abdominal pain, nausea, headache, and decreased appetite. The patients were treated with n-acetyl cysteine, 2,3-dimercaptopropane sulfonic acid, D-penicillamine, and meso 2,3-dimercaptosuccinic acid. A positive correlation was found between exposure time and urinary mercury level in the MI group (r = 0.793, P < 0.001). A positive moderate correlation was found between exposure time and blood level in the mercury exposure group (r = 0.535, P < 0.00). The neurological and systemic examinations of patients were all normal at the 1st follow-up visit 1 month after discharge. CONCLUSIONS: Diagnosis, removal of the exposure source, and use of chelation therapy can result in complete resolution of the signs and symptoms of MI.
Assuntos
Intoxicação por Mercúrio , Mercúrio , Acetilcisteína , Criança , Humanos , Intoxicação por Mercúrio/diagnóstico , Intoxicação por Mercúrio/tratamento farmacológico , Penicilamina/uso terapêutico , Prognóstico , Estudos Retrospectivos , Succímero/uso terapêutico , Ácidos SulfônicosRESUMO
BACKGROUND: There are no reports on the incidence of chronic mercury poisoning in a large population in China. This study investigated the epidemiology, clinical manifestations, treatment, and follow-up of Chinese patients with chronic mercury poisoning. METHODS: Data for 288 mercury poisoning patients were collected at our hospital from July 2014 to September 2019, including sex, age, admission time, blood mercury content, urine mercury content, creatinine, urinary mercury/creatinine ratio, 24-h urinary protein levels, electromyography (EMG) findings, renal biopsy, and follow-up. Patient characteristics were evaluated by statistical and correlation analyses. RESULTS: First, mercury poisoning in China mainly occurred through occupational exposure and the inappropriate use of mercury-containing cosmetics and Chinese folk remedies (CFRs). Second, the most common symptoms were nervous system (50.3 %), kidney (16.4 %) and breathing (8.0 %). Mercury poisoning-induced Nephrotic syndrome (NS) and peripheral neuropathy are common long-term complications. The complications of occupational and cosmetics-induced mercury poisoning are consistent with international belief. However, the NS caused by CFRs is mainly membranous nephropathy and the probability of peripheral neuropathy caused by CFRs is higher than other pathogens. Third, follow-up data shows that 13 patients with EMG-confirmed neurological injury, 10 showed full recovery after 38.50 ± 8.03 months. Furthermore, among 18 patients with NS, 15 had normal urine protein and serum albumin levels after 22.67 ± 10.26 months. CONCLUSIONS: Regulation of skin-lightening cosmetic products, safety surveillance of CFRs, and prevention and control of occupational exposure must be improved to decrease the incidence of mercury poisoning in China.
Assuntos
Intoxicação por Mercúrio , Doenças Profissionais , Adolescente , Adulto , Idoso , Anti-Inflamatórios/uso terapêutico , Quelantes/uso terapêutico , Criança , Pré-Escolar , China/epidemiologia , Doença Crônica , Cosméticos/toxicidade , Medicamentos de Ervas Chinesas/toxicidade , Feminino , Seguimentos , Humanos , Masculino , Mercúrio/sangue , Mercúrio/urina , Intoxicação por Mercúrio/sangue , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/epidemiologia , Intoxicação por Mercúrio/urina , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Doenças Profissionais/urina , Exposição Ocupacional/efeitos adversos , Prednisona/uso terapêutico , Estudos Retrospectivos , Unitiol/uso terapêutico , Adulto JovemRESUMO
Mercury is a toxic substance that is commonly used in skin lightening products. Various effects on humans have been observed, which affect both users and non-users. Many studies reported delayed diagnosis and treatment, even after weeks of hospitalization. The possible reasons are non-specific clinical manifestation and lack of awareness and knowledge regarding chronic mercury intoxication secondary to skin lightening products. A thorough history of mercury exposure is crucial. Physical assessment and relevant supporting tests are indicated to establish a diagnosis. Blood and urine mercury levels are an essential examination for diagnosis and monitoring of the progress and response to treatment. The primary treatment is the discontinuation of the skin lightening products. Chelation therapy is not mandatory and is usually indicated for symptomatic patients. The prognosis depends on the duration of the product use, concentration of mercury in the skin product, and the severity of clinical presentation.
Assuntos
Algoritmos , Cosméticos/intoxicação , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/etiologia , Pigmentação da Pele/efeitos dos fármacos , Terapia por Quelação , HumanosRESUMO
INTRODUCTION: Metallic mercury poisoning through intravenous injection is rare, especially as part of a suicide attempt. Diagnosis and treatment of the disease are challenging as clinical features are not specific. MATERIAL AND METODS: A 41-year-old male presented with dyspnea, fatigue, loss of weight, and loss of appetite over two months. Routine radiological examination by chest X-ray and CT showed randomly distributed high density opacities with Hounsfield units (HU) around 500 HU all over the body. The diagnosis was then confirmed with a urinary mercury concentration of > 1000 mcg/24 h. RESULTS: The patient's clinical condition was getting worse in spite of chelation therapy and hemodialysis. The patient eventually died because of respiratory failure. CONCLUSION: Early diagnosis and appropriate treatment are critical for intravenous mercury poisoning especially because there are no specific signs or symptoms. There should be a high level of suspicion in drug abusers. Treatment should involve the combined use of chelating agents and other treatments such as hemodialysis and plasma exchange in advanced clinical settings.
Assuntos
Quelantes/uso terapêutico , Intoxicação por Mercúrio/diagnóstico por imagem , Intoxicação por Mercúrio/tratamento farmacológico , Insuficiência Respiratória/induzido quimicamente , Adulto , Evolução Fatal , Humanos , Masculino , Embolia Pulmonar/induzido quimicamenteRESUMO
Copaifera langsdorffii L. is one of the most known medicinal species in Brazil. Its leaves are rich in phenolic compounds with potential biological activities as an antioxidant and chelating agent. This paper reports the isolation of four compounds from the hydroalcoholic extract of the leaves of C. langsdorffii and the investigation of their possible cytoprotective effects against heavy metal poisoning. Quercitrin (1), afzelin (2), 3,5-di-O-(3-O-methyl galloyl) quinic acid (3) and 4,5-di-O-(3-O-methyl galloyl) quinic acid (4), were associated with toxic doses of methylmercury and lead and evaluated by Alamar blue cell viability assays in HepG2 and PC12. The compounds displayed significant cytoprotective effect for the HepG2 cell line against both metals. Compounds 1-4 did not protect PC12 cells against methylmercury induced-cytotoxicity, but at lower concentrations, they protected against lead induced-cytotoxicity. The evaluated compounds showed a promising cytoprotection effect against exposure to heavy metals and should be further investigated as protective agents.
Assuntos
Fabaceae/química , Intoxicação por Metais Pesados/tratamento farmacológico , Compostos de Metilmercúrio/antagonistas & inibidores , Extratos Vegetais/farmacologia , Substâncias Protetoras/isolamento & purificação , Animais , Antioxidantes , Brasil , Linhagem Celular , Intoxicação por Metais Pesados/prevenção & controle , Humanos , Chumbo/toxicidade , Intoxicação por Chumbo/tratamento farmacológico , Intoxicação por Chumbo/prevenção & controle , Manosídeos , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/prevenção & controle , Compostos de Metilmercúrio/toxicidade , Fenóis , Folhas de Planta/química , Proantocianidinas , Substâncias Protetoras/farmacologia , Quercetina/análogos & derivados , Ácido Quínico , RatosRESUMO
A 17-year-old boy was referred after jumping from a ladder onto the ground, crushing a medical thermometer with his right foot. Some days later, he complained of loss of appetite and weakness. A radiograph of the affected foot demonstrated radiopaque densities. Blood and 24-h urine assays for mercury demonstrated toxic levels. Chelation therapy cured the patient dramatically.
Assuntos
Quelantes/uso terapêutico , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/etiologia , Termômetros/efeitos adversos , Adolescente , Traumatismos do Pé/diagnóstico por imagem , Traumatismos do Pé/patologia , Humanos , Masculino , Mercúrio/sangue , Mercúrio/urina , Intoxicação por Mercúrio/patologia , Intoxicação por Mercúrio/fisiopatologia , Radiografia , Resultado do TratamentoRESUMO
The present study aimed to evaluate the protective role of Selenium (Se) (0.1â¯ppm) on the male reproductive system of the catfish Clarias gariepinus exposed to sublethal doses of Mercury (Hg) (0.04 and 0.12â¯ppm) for 30â¯days. Indicators of seminal and gonadal hormone disruption (testosterone, estradiol and 11 keto testosterone), antioxidants (total antioxidant capacity (TAO), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx)), oxidative stress biomarkers (lipid peroxidation (LPO), percentage of DNA fragmentation, carbonylated proteins (CP) and nitric oxide (NO)) and histopathological alterations in testicles of Clarias gariepinus were determined. The exposure to Hg resulted in a high accumulation of residues of this metal in testicular tissues. The results showed a significant decrease in sperm count, activity and motility and in all gonadal hormones in Hg exposed groups. Hg exposure also induced a decline in TAO, SOD, CAT and GPx, whereas LPO, DNA fragmentation, CP and NO significantly increased in testicles of C. gariepinus respect to the control group. Although exposure to Se did not reduce the degree of mercury bioconcentration in the testicles, the sperm quality parameters were recovered. Moreover, TAO levels and GPx activity significantly increased after fish exposure to Se, whereas CP levels decreased. LPO, NO, CAT and SOD were also partially normalized when compared with the groups exposed to only Hg. In conclusion, the results showed that Hg, even in the small doses is capable to induce reproductive toxicity in the male catfish. Se exposure partially restored the values of biochemical parameters and sperm quality in Hg-treated fish suggesting protective effects against Hg reproductive toxicity.
Assuntos
Peixes-Gato/metabolismo , Mercúrio/toxicidade , Selênio/farmacologia , Espermatozoides , Testículo , Animais , Antioxidantes/metabolismo , Biomarcadores/metabolismo , Hormônios Gonadais/metabolismo , Masculino , Intoxicação por Mercúrio/tratamento farmacológico , Espermatozoides/efeitos dos fármacos , Espermatozoides/patologia , Testículo/efeitos dos fármacos , Testículo/patologia , Poluentes Químicos da Água/toxicidadeRESUMO
BACKGROUND: Mercury poisoning can cause damage to multiple organs. Secondary hypertension, which is usually misdiagnosed and mistreated, has been rarely reported in cases of mercury poisoning. METHODS: We herein present 2 cases of hypertension as the main manifestation of mercury poisoning. RESULTS: Case 1 involved a 42-year-old man with blood pressure of 230/190 mm Hg and urinary mercury level of 131.54 µmol/molCr. The patient had been repeatedly exposed to mercury at his workplace and had been admitted to our department many times. His hypertension quickly normalized after every chelation treatment. Case 2 involved a 10-year-old girl with hypertension (150/110 mm Hg), rash, and convulsions. She was found to have elevated blood levels of renin, angiotensin II, and aldosterone as well as an elevated urinary mercury level. Her hypertension recovered soon after chelation treatment. CONCLUSIONS: Mercury poisoning can cause secondary hypertension as the main clinical manifestation or together with multiorgan damage. Renin-angiotensin system activation may be involved in the occurrence and development of hypertension.
Assuntos
Terapia por Quelação/métodos , Hipertensão/diagnóstico , Intoxicação por Mercúrio/diagnóstico , Intoxicação por Mercúrio/tratamento farmacológico , Exposição Ocupacional/efeitos adversos , Adulto , Criança , Diagnóstico Diferencial , Erros de Diagnóstico , Feminino , Humanos , Hipertensão/tratamento farmacológico , Masculino , Medição de Risco , Índice de Gravidade de DoençaRESUMO
BACKGROUND: Mercury poisoning is an uncommon diagnosis in the United States, but it is a differential diagnosis that physicians should consider because it can lead to potentially fatal complications if untreated. Due to the nonspecific presentation of mercury poisoning, which includes symptoms such as fever, nausea, vomiting, and abdominal pain, misdiagnosis may occur unless a proper history is taken. CASE REPORT: In the present case, a white female patient was misdiagnosed repeatedly with a viral illness and sent home from the local hospital. The patient presented with a diffuse full-body rash, fever, myalgias, headache, peripheral neuropathy, oral paresthesias, and tender cervical posterior lymphadenopathy. After obtaining a thorough history, it was discovered that the patient and her family were exposed to mercury through a spill of elemental mercury in their home. Blood mercury levels in the patient were 170 ng/mL. The patient was treated with a course of dimercaprol. Her symptoms improved and she was discharged on hospital day 5. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Ultimately, mercury poisoning is a treatable condition, but if exposure continues and the patient is not treated, it may lead to complications such as severe pneumonitis, renal tubular necrosis, and neurological dysfunction. In some instances, neurological symptoms may persist even if the source of exposure is removed. For these reasons, recognition and prompt treatment after a suspected exposure is important.
Assuntos
Intoxicação por Mercúrio/diagnóstico , Intoxicação por Mercúrio/tratamento farmacológico , Adulto , Quelantes/uso terapêutico , Terapia por Quelação/métodos , Serviço Hospitalar de Emergência/organização & administração , Exposição Ambiental/efeitos adversos , Exantema/etiologia , Feminino , Febre/etiologia , Humanos , Mercúrio/análise , Mercúrio/sangue , Mercúrio/urina , Intoxicação por Mercúrio/complicações , Mialgia/etiologia , Succímero/uso terapêuticoRESUMO
BACKGROUND: Fixed drug eruptions (FDE) are characterized by recurrent, usually solitary erythematous or dark red macular, plaque or bullous lesions, all at the same site. Among the first choices for antidotal treatment in mercury exposure, 2,3-dimercapto-1-propanesulfonic acid (DMPS) is generally a drug with a low incidence of side effects. FDE due to DMPS was not detected in our literature research and so we aimed to present this rare case. CASE REPORT: Forty-eight-year-old male patient, gunpowder and explosives factory worker, was admitted to our hospital because of mercury exposure and we started DMPS treatment. On the second day of chelation treatment, swelling and felting on lips and complaints of wound formation in genital areas started. Annular, purple color plaque on penis with no angioedema was observed. Case was regarded as FDE. Systemic and topical steroid therapy was started after termination of chelation therapy and lesions regressed with steroids. DISCUSSION: Drug eruptions are substantially common dermatological problems and can be seen in about 2.2% of inpatients. The most common unexpected effects of DMPS are allergic skin reactions. The clinical state regress rapidly after the cessation of chelation therapy.
Assuntos
Quelantes/efeitos adversos , Toxidermias/tratamento farmacológico , Intoxicação por Mercúrio/tratamento farmacológico , Unitiol/efeitos adversos , Quelantes/uso terapêutico , Toxidermias/etiologia , Glucocorticoides/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Doenças do Pênis/induzido quimicamente , Doenças do Pênis/tratamento farmacológico , Unitiol/uso terapêuticoRESUMO
This work investigated the preventive effect of diphenyl diselenide [(PhSe)2] against the toxic effects of mercury in silver catfish (Rhamdia quelen). The animals were treated during 30 consecutive days with a (PhSe)2 supplemented feed (3.0 mg kg-1) or commercial feed. During the last 5 days the animals received a daily intraperitoneal dose of HgCl2 (1.7 mg kg-1) or Saline (0.9%). Twenty-four hours after the last HgCl2 injection, the animals were euthanized by spinal cord section to biological material obtainment. Hepatic (AST and ALT) and renal (ammonia and creatinine) toxicity biomarkers, δ-ALA-D activity, TBARS, total and non-protein thiols levels and hepatic, renal and blood mercury (Hg) and zinc (Zn) content were evaluated. Considering renal parameters, HgCl2 exposition increased serum creatinine levels and decreased δ-ALA-D activity, total and non-protein thiols and TBARS levels. HgCl2 exposure also decreased blood δ-ALA-D activity. With exception of blood δ-ALA-D activity and total thiols levels, (PhSe)2 supplementation partially prevented mercury induced alterations. Animals exposed to HgCl2 presented an increase in liver and kidney Hg content and a decrease in liver and blood Zn content. The alteration in blood Zn content was partially prevented with (PhSe)2 supplementation. With the exception of mercury and zinc content, no effects of HgCl2 exposure on hepatic tissue were observed. These results show that (PhSe)2 supplementation can represent a promising alternative to prevent the toxic effects presented by Hg exposure.
Assuntos
Derivados de Benzeno/farmacologia , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/prevenção & controle , Compostos Organosselênicos/farmacologia , Animais , Derivados de Benzeno/metabolismo , Peixes-Gato/metabolismo , Creatinina/sangue , Dieta , Suplementos Nutricionais , Feminino , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Cloreto de Mercúrio/administração & dosagem , Mercúrio/sangue , Intoxicação por Mercúrio/sangue , Compostos Organosselênicos/metabolismo , Compostos de Sulfidrila/sangue , Zinco/sangueAssuntos
Ataxia Cerebelar/induzido quimicamente , Ayurveda/efeitos adversos , Intoxicação por Mercúrio/complicações , Mercúrio/sangue , Adulto , Ataxia Cerebelar/sangue , Ataxia Cerebelar/tratamento farmacológico , Quelantes/uso terapêutico , Dimercaprol/uso terapêutico , Humanos , Masculino , Intoxicação por Mercúrio/sangue , Intoxicação por Mercúrio/tratamento farmacológico , Resultado do TratamentoRESUMO
A 13-year-old African American male presented with 2 months of subacute altered mental status, ptosis, areflexia, disordered gait, constipation, weight loss, abdominal and testicular pain, and hyperhidrosis. Initial workup at our facility was unrevealing until elevated serum mercury level was detected. Diagnosis of mercury toxicity was confirmed, and chelation therapy with succimer was started. After beginning succimer, the patient developed acute-onset weakness and was diagnosed with acute inflammatory demyelinating polyneuropathy. Supportive studies included elevated cerebrospinal fluid protein and acquired demyelinating polyneuropathy on nerve conduction study. He responded well to treatment with intravenous immunoglobulin and returned to his baseline state of health. Although there is a known association between mercury toxicity and axonal neuropathy, there is only 1 other case report of acute inflammatory demyelinating polyneuropathy in the setting of mercury toxicity. The nature of the correlation between these 2 entities in our case remains unclear.
Assuntos
Síndrome de Guillain-Barré/complicações , Intoxicação por Mercúrio/complicações , Adolescente , Eletromiografia , Potencial Evocado Motor/fisiologia , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/tratamento farmacológico , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Masculino , Intoxicação por Mercúrio/diagnóstico , Intoxicação por Mercúrio/tratamento farmacológico , Condução Nervosa/fisiologiaRESUMO
BACKGROUND: Chronic mercury intoxication is a severe health issue and occurs especially in gold mining communities. Common chelators used for improving mercury elimination are not everywhere available and challenged by poor cell wall penetration. This study is part of a feasibility trial and the aim was to gather first information about the efficacy of the newly developed chelator N,N'bis-(2-mercaptoethyl) isophthalamide (NBMI) on chronic mercury intoxication. METHODS: In this three-armed, placebo-controlled randomized trial, 36 miners with mercury urine levels exceeding 15 µg/l were administered 100 mg NBMI, 300 mg NBMI or placebo for 14 days. Levels of mercury in urine [µg/l and µg/g creatinine] and plasma l were analyzed. Therapeutic effect was assessed using the medical intoxication score (MIS) and its single health outcomes (e.g. excessive salivation, sleeping problems), fatigue scores, a neuromotoric test battery (CATSYS) and a neurological outcome (Finger to nose test). RESULTS: Physical fatigue was significantly decreased in the 300 mg NBMI group compared to the control. Mercury concentration in urine following 300 mg NBMI treatment was significantly lowered compared to control, however, this effect was less distinct with adjustment for creatinine. CONCLUSION: NBMI showed an effect on physical fatigue and there were indications to positive effects on other symptoms as well. More comprehensive studies are mandatory to verify the effects of NBMI as a novel tool for treating mercury intoxications. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02486289 . Date of registration: June 24, 2015.
Assuntos
Quelantes/uso terapêutico , Cisteamina/análogos & derivados , Poluentes Ambientais/urina , Intoxicação por Mercúrio/tratamento farmacológico , Mercúrio/urina , Exposição Ocupacional , Ácidos Ftálicos/uso terapêutico , Adulto , Cisteamina/uso terapêutico , Relação Dose-Resposta a Droga , Ouro , Hispânico ou Latino , Humanos , Masculino , Pessoa de Meia-Idade , Mineração , Adulto JovemRESUMO
The antagonism of mercury toxicity by selenium has been well documented. Mercury is a toxic metal, widespread in the environment. The main target organs (kidneys, lungs, or brain) of mercury vary depending on its chemical forms (inorganic or organic). Selenium is a semimetal essential to mammalian life as part of the amino acid selenocysteine, which is required to the synthesis of the selenoproteins. This chapter has the aim of disclosing the role of selenide or hydrogen selenide (Se-2 or HSe-) as central metabolite of selenium and as an important antidote of the electrophilic mercury forms (particularly, Hg2+ and MeHg). Emphasis will be centered on the neurotoxicity of electrophile forms of mercury and selenium. The controversial participation of electrophile mercury and selenium forms in the development of some neurodegenerative disease will be briefly presented. The potential pharmacological use of organoseleno compounds (Ebselen and diphenyl diselenide) in the treatment of mercury poisoning will be considered. The central role of thiol (-SH) and selenol (-SeH) groups as the generic targets of electrophile mercury forms and the need of new in silico tools to guide the future biological researches will be commented.
Assuntos
Encéfalo/metabolismo , Intoxicação do Sistema Nervoso por Mercúrio/metabolismo , Síndromes Neurotóxicas/etiologia , Selênio/intoxicação , Antídotos/uso terapêutico , Azóis/uso terapêutico , Derivados de Benzeno/uso terapêutico , Humanos , Isoindóis , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/metabolismo , Intoxicação do Sistema Nervoso por Mercúrio/tratamento farmacológico , Síndromes Neurotóxicas/tratamento farmacológico , Síndromes Neurotóxicas/metabolismo , Compostos Organosselênicos/uso terapêutico , Selenoproteínas/metabolismoRESUMO
Mercury (Hg) poisoning is considered a rare disease by the National Institutes of Health and the diagnosis can present great challenges to clinicians. Children who are exposed to Hg can present with a wide variety of symptoms, including acrodynia, tremor, excessive salivation, and psychiatric symptoms, including insomnia. However, endocrinologic manifestations from Hg exposure are less well known. This is a case report of a 12-year-old boy who presented with body rash, irritability, insomnia, and profuse sweating after returning from a summer camp. The child was initially managed in the outpatient setting, and the investigation was mainly targeted toward infectious etiology, including Rocky Mountain spotted fever and Lyme disease. He was eventually admitted to the hospital with altered mental status and was noted to have hyponatremia with serum sodium of 121 mEq/L. Thyroid studies also revealed elevated free thyroxine levels in the presence of normal triiodothyronine and thyrotropin. The patient developed hypertension and tachycardia, and was found to have elevated 24-hour vanillylmandelic acid and metanephrines. Finally, heavy metal measurements revealed a blood Hg level that was greater than the reference values of 0 to 9 ng/mL. Chelation treatment with 2,3-dimercaptopropane-1-sulfonate was subsequently initiated and over a period of 8 months his symptoms resolved and his thyroid function test returned to normal. This case highlights some of the challenges commonly encountered in identifying Hg exposure. More importantly, it illustrates that exposure to Hg should be considered in children who present with the symptoms and abnormal endocrinologic test results described in this report.
Assuntos
Hipertireoxinemia/diagnóstico , Hiponatremia/diagnóstico , Intoxicação por Mercúrio/diagnóstico , Metanefrina/sangue , Doenças Raras , Ácido Vanilmandélico/sangue , Terapia por Quelação , Criança , Diagnóstico Diferencial , Humanos , Hipertireoxinemia/etiologia , Hiponatremia/etiologia , Masculino , Intoxicação por Mercúrio/tratamento farmacológico , Admissão do Paciente , Unitiol/uso terapêuticoRESUMO
AIM: Membranous nephropathy and minimal change disease (MCD) have been involved in mercury-induced nephrotic syndrome. IgA nephropathy is not known to be a common pathological type. In the present article, we report a case of IgA nephropathy with MCD following exposure to mercury-containing skin lightening cream. MATERIAL AND METHODS: The patient was a 39-year-old woman who presented with nephrotic syndrome. She had a 6-month history of using as many as 8 kinds of skin-lightening creams, and urinary mercury excretion was high. Renal biopsy revealed IgA nephropathy with MCD. The use of cosmetics was stopped and chelation therapy was given. After 4 courses (1 month) of chelation therapy, there was a complete remission of proteinuria and hematuria, and urine tests remained normal during the 5-year follow-up period. RESULTS AND CONCLUSIONS: The unique clinical and pathological features of IgA nephropathy with MCD had raised the controversial question of whether MCD and IgA deposition are separate entities or a common pathophysiology. Repeated renal biopsy and similar cases were helpful and should be carried out as far as possible.â©.
Assuntos
Glomerulonefrite por IGA/induzido quimicamente , Intoxicação por Mercúrio/complicações , Nefrose Lipoide/induzido quimicamente , Preparações Clareadoras de Pele/intoxicação , Adulto , Quelantes/uso terapêutico , Feminino , Glomerulonefrite por IGA/patologia , Glomerulonefrite por IGA/terapia , Hematúria/etiologia , Humanos , Rim/patologia , Rim/ultraestrutura , Intoxicação por Mercúrio/tratamento farmacológico , Nefrose Lipoide/patologia , Nefrose Lipoide/terapia , Síndrome Nefrótica/etiologia , Síndrome Nefrótica/terapia , Proteinúria/etiologia , Indução de Remissão , Preparações Clareadoras de Pele/química , Unitiol/uso terapêuticoRESUMO
The efficacy of treatment for intravenous elemental mercury intoxication has not been fully studied with regard to clinical outcome, and treatment recommendations vary. We treated a 41-year-old man with a history of drug abuse and depression who attempted suicide using 1 mL (13.53 g) metallic Hg i.v. He was admitted to the hospital 2 months later for dyspnoea and thoracic pain and was diagnosed with pneumonia. Hg deposits were seen in the lungs and extra-pulmonary organs. His blood level (372 µg/L) exceeded the population level of 5 µg/L by more than 70 times. Dimercaptopropane sulphonate sodium (DMPS; 600 mg/day orally) was administered for 14 days. One year later, the patient presented with dyspnoea on exertion, fatigue, depression and impaired sleep. His chest X-ray showed multiple opacities (size up to 2.8 cm), and psychological testing revealed a selective cognitive deficit in the area of visual attentiveness, flexibility, source memory and impairment of the motor speed of the dominant upper extremity. Mercury blood level was 158 µg/L and mercury urine output was 1380 µg/24 hr. DMPS (800 mg/day orally) was administered for 40 days; the patient eliminated up to 18 mg Hg/day. His Hg blood level and Hg urine output belong to the highest among reported cases. In spite of the therapy, the patient's blood Hg, complaints and psychological tests showed no improvement. This case report confirms that DMPS does not effectively remove intravenous deposits of metallic Hg.